RMD ResMed Inc.
Stock · NYSE · United States · Healthcare · US7611521078
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by ResMed Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
235.30 USD
-1.68%
52-week range
180.27 – 277.67
Dividend yield1.12%
Market cap33.1B
NowoTrade score
72 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:50. Information, not advice.
Results
Next results
28 Jan 2027
in 81 days · 16:00 · estimate 2.99
Last results
2.91 vs 2.67 estimated
29 Oct 2026 · Beat +8.9%
Beat the estimate
10 of 12
0 missed · 2 in line · 6 beats in a row
Average surprise
+4.3%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 28 Jan 2027 16:00 | 2.99 | — | — | Upcoming |
| 29 Oct 2026 16:00 | 2.67 | 2.91 | +8.9% | Beat |
| 06 Aug 2026 16:00 | 2.89 | 2.95 | +2.0% | Beat |
| 30 Apr 2026 16:00 | 2.80 | 2.86 | +2.2% | Beat |
| 29 Jan 2026 16:00 | 2.72 | 2.81 | +3.2% | Beat |
| 30 Oct 2025 16:00 | 2.50 | 2.55 | +2.1% | Beat |
| 31 Jul 2025 16:00 | 2.48 | 2.55 | +2.8% | Beat |
| 23 Apr 2025 16:00 | 2.36 | 2.37 | +0.4% | In line |
| 30 Jan 2025 16:00 | 2.31 | 2.43 | +5.0% | Beat |
| 24 Oct 2024 16:00 | 2.04 | 2.20 | +7.7% | Beat |
| 01 Aug 2024 16:00 | 2.07 | 2.08 | +0.5% | In line |
| 25 Apr 2024 16:00 | 1.91 | 2.13 | +11.7% | Beat |
| 24 Jan 2024 16:00 | 1.78 | 1.88 | +5.5% | Beat |
| 26 Oct 2023 16:00 | 1.61 | 1.64 | +1.7% | Beat |
| 03 Aug 2023 16:00 | 1.69 | 1.60 | -5.4% | Miss |
| 27 Apr 2023 16:00 | 1.59 | 1.68 | +5.5% | Beat |
| 26 Jan 2023 16:00 | 1.62 | 1.66 | +2.6% | Beat |
| 27 Oct 2022 16:00 | 1.60 | 1.51 | -5.7% | Miss |
| 11 Aug 2022 16:00 | 1.46 | 1.49 | +2.4% | Beat |
| 28 Apr 2022 16:00 | 1.44 | 1.32 | -8.1% | Miss |
| 27 Jan 2022 16:00 | 1.52 | 1.47 | -3.5% | Miss |
| 28 Oct 2021 16:00 | 1.35 | 1.51 | +11.7% | Beat |
| 05 Aug 2021 16:00 | 1.29 | 1.35 | +4.6% | Beat |
| 29 Apr 2021 16:00 | 1.27 | 1.30 | +2.4% | Beat |
| 28 Jan 2021 16:00 | 1.28 | 1.41 | +10.5% | Beat |
| 29 Oct 2020 16:00 | 1.03 | 1.27 | +23.7% | Beat |
| 05 Aug 2020 16:00 | 1.07 | 1.33 | +24.3% | Beat |
| 30 Apr 2020 17:00 | 1.08 | 1.29 | +19.4% | Beat |
| 30 Jan 2020 16:00 | 1.02 | 1.21 | +18.5% | Beat |
| 24 Oct 2019 16:00 | 0.87 | 0.93 | +6.6% | Beat |
| 25 Jul 2019 16:00 | 0.92 | 0.95 | +3.4% | Beat |
| 02 May 2019 16:00 | 0.85 | 0.89 | +4.1% | Beat |
| 24 Jan 2019 16:00 | 0.95 | 1.00 | +5.2% | Beat |
| 25 Oct 2018 16:00 | 0.79 | 0.81 | +2.6% | Beat |
| 02 Aug 2018 16:00 | 0.93 | 0.95 | +1.9% | Beat |
| 26 Apr 2018 16:00 | 0.86 | 0.92 | +7.6% | Beat |
| 22 Jan 2018 16:00 | 0.78 | 1.00 | +29.0% | Beat |
| 26 Oct 2017 16:00 | 0.66 | 0.66 | +0.1% | In line |
| 01 Aug 2017 16:00 | 0.74 | 0.77 | +3.5% | Beat |
| 27 Apr 2017 16:00 | 0.70 | 0.71 | +1.5% | Beat |
| 23 Jan 2017 16:00 | 0.70 | 0.73 | +4.7% | Beat |
| 25 Oct 2016 16:00 | 0.65 | 0.62 | -4.9% | Miss |
| 28 Jul 2016 16:00 | 0.75 | 0.74 | -1.0% | Miss |
| 26 Apr 2016 16:00 | 0.68 | 0.68 | 0.0% | In line |
| 21 Jan 2016 16:00 | 0.66 | 0.69 | +4.6% | Beat |
| 22 Oct 2015 16:00 | 0.60 | 0.58 | -2.5% | Miss |
| 30 Jul 2015 16:00 | 0.65 | 0.68 | +3.9% | Beat |
| 23 Apr 2015 16:00 | 0.66 | 0.65 | -1.9% | Miss |
| 22 Jan 2015 16:00 | 0.61 | 0.65 | +6.4% | Beat |
| 23 Oct 2014 16:00 | 0.57 | 0.59 | +3.9% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 5.7B | +9.9% | 1.5B | 26.9% | 10.43 | — | 1.6B |
| 2025 | 5.1B | +9.8% | 1.4B | 27.2% | — | — | 1.7B |
| 2024 | 4.7B | +10.9% | 1B | 21.8% | 6.92 | +13.6% | 1.3B |
| 2023 | 4.2B | — | 897.6M | 21.3% | 6.09 | +14.9% | 559.3M |
| 2022 | — | — | — | — | 5.30 | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 29 Feb 2024 | 174.43 | 174.74 | 171.67 | 173.72 | -0.14% | 1,613,300 | |
| 28 Feb 2024 | 180.99 | 181.16 | 171.99 | 173.96 | -3.88% | 1,410,100 | |
| 27 Feb 2024 | 183.15 | 184.10 | 180.96 | 180.99 | -1.25% | 666,700 | |
| 26 Feb 2024 | 184.04 | 185.38 | 181.70 | 183.29 | -0.41% | 965,400 | |
| 23 Feb 2024 | 183.10 | 185.80 | 183.10 | 184.04 | +0.51% | 675,500 | |
| 22 Feb 2024 | 180.26 | 183.51 | 179.01 | 183.10 | +1.56% | 706,100 | |
| 21 Feb 2024 | 180.50 | 180.83 | 178.64 | 180.29 | -0.20% | 620,100 | |
| 20 Feb 2024 | 180.46 | 181.05 | 179.18 | 180.66 | +0.11% | 660,200 | |
| 16 Feb 2024 | 181.63 | 183.88 | 180.18 | 180.46 | -1.18% | 666,600 | |
| 15 Feb 2024 | 182.47 | 184.24 | 180.31 | 182.61 | +1.14% | 604,000 | |
| 14 Feb 2024 | 179.55 | 180.98 | 178.74 | 180.55 | +0.77% | 468,300 | |
| 13 Feb 2024 | 179.65 | 181.62 | 178.49 | 179.17 | -1.84% | 731,300 | |
| 12 Feb 2024 | 179.87 | 184.00 | 179.72 | 182.52 | -1.14% | 881,700 | |
| 09 Feb 2024 | 184.84 | 185.95 | 182.27 | 184.63 | +0.48% | 747,700 | |
| 08 Feb 2024 | 185.68 | 186.07 | 181.74 | 183.75 | -1.52% | 897,100 | |
| 07 Feb 2024 | 190.35 | 190.51 | 186.52 | 186.59 | -2.17% | 979,900 | 0.4800 |
| 06 Feb 2024 | 190.29 | 192.64 | 186.07 | 190.72 | +0.32% | 1,302,600 | |
| 05 Feb 2024 | 191.20 | 192.44 | 190.09 | 190.11 | -0.91% | 815,900 | |
| 02 Feb 2024 | 191.98 | 193.27 | 190.89 | 191.86 | -0.93% | 617,600 | |
| 01 Feb 2024 | 190.44 | 193.83 | 189.80 | 193.66 | +1.82% | 823,400 | |
| 31 Jan 2024 | 192.31 | 193.04 | 189.76 | 190.20 | -0.62% | 767,800 | |
| 30 Jan 2024 | 190.80 | 192.34 | 189.68 | 191.38 | +0.08% | 730,500 | |
| 29 Jan 2024 | 189.95 | 197.85 | 188.50 | 191.23 | +0.57% | 1,625,900 | |
| 26 Jan 2024 | 187.98 | 195.74 | 187.00 | 190.15 | +2.04% | 2,336,900 | |
| 25 Jan 2024 | 189.56 | 190.04 | 181.10 | 186.35 | +8.48% | 2,473,200 |
Page 28 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Don’t Lose Sleep Over GLP-1s: Why ResMed Stock Is a Bargain (opens in a new tab) Barrons.com · 07 Nov 2026 03:04
- ResMed: A Quality Compounder, But Not Yet A Bargain (opens in a new tab) SeekingAlpha · 03 Nov 2026 11:16
- ResMed: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 02 Nov 2026 09:33
- What Sent ResMed Stock Lower? (opens in a new tab) Trefis · 02 Nov 2026 01:23
- RMD Q3 deep dive: product innovation and supply chain execution drive results amid evolving landscape (opens in a new tab) StockStory · 31 Oct 2026 23:07
- ResMed (RMD) Looks Fully Valued After Another Earnings Beat (opens in a new tab) Simply Wall St. · 30 Oct 2026 19:16
- ResMed (RMD) Q1 2027 Earnings Call Transcript (opens in a new tab) Motley Fool · 30 Oct 2026 15:00
- ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 30 Oct 2026 12:30
- ResMed Inc. Q1 2027 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
- What ResMed (RMD) Said on Its Q1 Earnings Call (opens in a new tab) MarketBeat · 30 Oct 2026 11:14
- RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs (opens in a new tab) Zacks · 30 Oct 2026 10:28
- ResMed (NYSE:RMD) posts better-than-expected sales in Q3 CY2026 (opens in a new tab) StockStory · 29 Oct 2026 20:53
- ResMed (RMD) Beats Q1 Earnings and Revenue Estimates (opens in a new tab) Zacks · 29 Oct 2026 20:35
- ResMed: Fiscal Q1 Earnings Snapshot (opens in a new tab) Associated Press · 29 Oct 2026 20:16
- Unlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key Metrics (opens in a new tab) Zacks · 28 Oct 2026 12:15
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 239.31 USD
- Market cap
- 33.1B
- Dividend yield
- 1.12%
- 5-year average yield
- 0.87%
- Payout ratio
- 22%
- Last dividend
- 0.6600 USD · 12 Nov 2026
- Next ex-dividend date
- 12 Nov 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 20 Aug 2026 | 0.6600 USD |
| 14 May 2026 | 0.6000 USD |
| 12 Feb 2026 | 0.6000 USD |
| 13 Nov 2025 | 0.6000 USD |
| 14 Aug 2025 | 0.6000 USD |
| 08 May 2025 | 0.5300 USD |
| 13 Feb 2025 | 0.5300 USD |
| 07 Nov 2024 | 0.5300 USD |
| 15 Aug 2024 | 0.5300 USD |
| 08 May 2024 | 0.4800 USD |
| 07 Feb 2024 | 0.4800 USD |
| 08 Nov 2023 | 0.4800 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 4.7 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 25.0 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 15.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 13.2 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 8.2 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 3.7 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 21.43× | Fair | 30.3× |
| P/E (forward) | 17.79× | Fair | 14.94× |
| Price / book | 5.56× | Weak | 3.81× |
| Price / sales | 5.77× | Weak | 3.19× |
| EV / EBITDA | 15.38× | Weak | 12.63× |
| Free cash flow yield | 3.9% | Fair | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 61.8% | Good | 58.6% |
| Operating margin | 34.8% | Good | 7.8% |
| Net margin | 27.8% | Good | 2.8% |
| Return on equity | 26.4% | Good | 5.7% |
| Return on assets | 14.8% | Good | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 10.2% | Good | 10.8% |
| EPS growth / year | 18.4% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.1× | Good | 0.48× |
| Net debt / EBITDA | -0.19× | Good | 1.58× |
| Current ratio | 2.65× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 22.4% | Good | 0% |
| Payout of free cash flow | 26.9% | Good | 28.9% |
| Payout of free cash flow (3 years) | 20.6% | Good | — |
| Dividend growth / year | 8.6% | Good | 7.1% |
| Years of rising dividends | 12 | Good | 3 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow RMD and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.